RediTrex — CareFirst (Caremark)

Preferred products

• generic oral methotrexate
• generic injectable methotrexate

Initial criteria

• Member has an inadequate response or intolerance to generic oral methotrexate
• Member has an inability to prepare and administer generic injectable methotrexate

Reauthorization criteria

• Member meets all initial coverage criteria
• Member has achieved or maintained a positive clinical response after at least 3 months of therapy as evidenced by low disease activity or improvement in signs and symptoms

Approval duration

12 months